About Mussel Polymers
Mussel Polymers is a company based in Bethlehem (United States) founded in 2019 by Jason Stieg. Mussel Polymers has raised $7.33 million across 3 funding rounds from investors including Ben Franklin Technology Partners. Mussel Polymers offers products and services including Dental Adhesive, Coral Restoration Adhesive, Defense Adhesive, and Electronics Adhesive. Mussel Polymers operates in a competitive market with competitors including Adhezion Biomedical, RadiSurf, Inno Therapy, HyperBranch Medical and BRIJ Medical, among others.
- Headquarter Bethlehem, United States
- Founders Jason Stieg
-
Sectors
HealthcareChemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mussel Polymers, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.33 M (USD)
in 3 rounds
-
Latest Funding Round
$4.83 M (USD), Series A
Dec 31, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mussel Polymers
Mussel Polymers offers a comprehensive portfolio of products and services, including Dental Adhesive, Coral Restoration Adhesive, Defense Adhesive, and Electronics Adhesive.
Adhesives for dental fillings, crowns, and implants in wet environments.
Glue for underwater coral propagation and safe planting.
Adhesives for bonding on military ships and vehicles in wet conditions.
Adhesives for PCBs, solar panels, and batteries in challenging environments.
Funding Insights of Mussel Polymers
Mussel Polymers has successfully raised a total of $7.33M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.83 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.8M
-
First Round
First Round
(26 Oct 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Series A - Mussel Polymers | Valuation |
investors |
|
| Oct, 2025 | Amount | Seed - Mussel Polymers | Valuation |
investors |
|
| Oct, 2023 | Amount | Seed - Mussel Polymers | Valuation | Ben Franklin Technology Partners |
|
Investors in Mussel Polymers
Mussel Polymers has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and support are provided for Pennsylvania's tech-based companies.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mussel Polymers
Financial Statements - Mussel Polymers
Mussel Polymers Comparisons
Competitors of Mussel Polymers
Mussel Polymers operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, RadiSurf, Inno Therapy, HyperBranch Medical and BRIJ Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
|
|
| domain | founded_year | HQ Location |
Nano adhesive systems for bonding plastics to metals are developed.
|
|
| domain | founded_year | HQ Location |
Hemostatic polymers are produced for surgical and wound care applications.
|
|
| domain | founded_year | HQ Location |
Biosurgical devices are developed using proprietary polymers and hydrogels.
|
|
| domain | founded_year | HQ Location |
Medical devices for post-surgical and trauma incision care are provided.
|
|
| domain | founded_year | HQ Location |
Wound closure devices for skin are manufactured by Suturegard.
|
Frequently Asked Questions about Mussel Polymers
Mussel Polymers was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Mussel Polymers is headquartered in Bethlehem, United States.
George Boyajian is the current CEO of Mussel Polymers.
Mussel Polymers is a funded company, having raised a total of $7.33M across 3 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Oct 26, 2023.
Mussel Polymers was founded in 2019 and is based in Bethlehem, United States. Adhesive solutions are produced for applications involving materials such as wood, steel, aluminum, styrene, acrylic, urethane, epoxy, polyester, TPU, and TPO. A platform is provided to users for accessing these products. Operations extend to sectors including defense, corals, and electronics, with a focus on manufacturing and distribution in the adhesives industry.
Mussel Polymers's top competitors include Adhezion Biomedical, BRIJ Medical and RadiSurf.
Mussel Polymers offers Dental Adhesive, Coral Restoration Adhesive, Defense Adhesive, and Electronics Adhesive.
Mussel Polymers has 1 investor. Key investors include Ben Franklin Technology Partners.